FDA Early Alert: Abbott Diabetes Care Glucose Monitor Sensors Recall and Replacement Information
The Food and Drug Administration has issued an Early Alert regarding potentially faulty glucose monitor sensors produced by Abbott Diabetes Care. These sensors may be providing incorrect low glucose readings for users with diabetes, which could lead to incorrect treatment decisions and serious health risks. Abbott has received reports of severe adverse events and potential deaths associated with the faulty sensors, prompting the company to urge users to check if their FreeStyle Libre 3 and FreeStyle Libre 3 Plus sensors are affected.
The FDA also issued an Early Alert communication, warning the public about the high-risk issue and advising users with impacted devices to immediately discontinue use and dispose of the sensors. Users can request a replacement device free of charge from Abbott. The affected products and their identifying information can be found in the FDA's Early Alert.
Continuous glucose monitors are essential for people with diabetes to monitor their glucose levels in real time. The device's sensor transmits glucose information to an app or receiver, allowing users to make informed decisions about their diet, physical activity, and medication. It is crucial for users to ensure the accuracy of their glucose monitor sensors to avoid potential health complications.
In conclusion, users of Abbott's FreeStyle Libre 3 and FreeStyle Libre 3 Plus continuous glucose monitor sensors should be aware of the potential issue with incorrect low glucose readings. It is important to follow the FDA's Early Alert guidance and take necessary steps to ensure the accuracy of glucose monitoring for better diabetes management and overall health.